Australia markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
118.74+0.74 (+0.63%)
At close: 4:00PM EST

118.90 +0.16 (0.13%)
Pre-market: 5:07AM EST

Currency in USD

Valuation measures

Market cap (intra-day) 5159.83B
Enterprise value 3174.86B
Trailing P/E 52.56
Forward P/E 120.69
PEG ratio (5-yr expected) 13.02
Price/sales (ttm)5.72
Price/book (mrq)3.15
Enterprise value/revenue 36.26
Enterprise value/EBITDA 627.13

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 316.85%
S&P500 52-week change 323.92%
52-week high 3120.53
52-week low 372.13
50-day moving average 3116.82
200-day moving average 3110.18

Share statistics

Avg vol (3-month) 34.38M
Avg vol (10-day) 36.14M
Shares outstanding 51.35B
Float 1.35B
% held by insiders 10.06%
% held by institutions 183.39%
Shares short (28 Jan 2021) 47.35M
Short ratio (28 Jan 2021) 41.82
Short % of float (28 Jan 2021) 40.55%
Short % of shares outstanding (28 Jan 2021) 40.55%
Shares short (prior month 30 Dec 2020) 46.6M

Dividends & splits

Forward annual dividend rate 42.32
Forward annual dividend yield 41.97%
Trailing annual dividend rate 32.28
Trailing annual dividend yield 31.93%
5-year average dividend yield 42.08
Payout ratio 485.82%
Dividend date 314 Jan 2021
Ex-dividend date 420 Dec 2020
Last split factor 22:1
Last split date 326 Sep 1999

Financial highlights

Fiscal year

Fiscal year ends 23 Apr 2020
Most-recent quarter (mrq)28 Jan 2021

Profitability

Profit margin 10.97%
Operating margin (ttm)14.15%

Management effectiveness

Return on assets (ttm)2.60%
Return on equity (ttm)5.97%

Income statement

Revenue (ttm)27.93B
Revenue per share (ttm)20.79
Quarterly revenue growth (yoy)0.80%
Gross profit (ttm)19.64B
EBITDA 6.45B
Net income avi to common (ttm)3.06B
Diluted EPS (ttm)2.26
Quarterly earnings growth (yoy)-33.70%

Balance sheet

Total cash (mrq)14.64B
Total cash per share (mrq)10.86
Total debt (mrq)30.32B
Total debt/equity (mrq)59.54
Current ratio (mrq)2.10
Book value per share (mrq)37.67

Cash flow statement

Operating cash flow (ttm)5.94B
Levered free cash flow (ttm)5.55B